GVR Report cover CyberKnife Market Size, Share & Trends Report

CyberKnife Market Size, Share & Trends Analysis Report By Application (Tumor, Cancer, Vascular malformation and Others), By End-use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Others), By Region, And Segment Forecasts, 2023 To 2030

  • Report ID: GVR453635
  • Number of Pages: 0
  • Format: Electronic (PDF)

CyberKnife treatment offers various benefits such as excellent long-term cancer control, reduced incidence of urinary, sexual, and bowel function side effects and it is non-invasive and non-surgical. These benefits represent lucrative growth opportunities for the cyberknife market over the forecast period. Moreover, recent product launches by key manufacturers in the market is also expected to drive the growth of the cyberknife market.   

The growing prevalence of cancer such as prostate and lung is another major factor contributing to the rapid growth of the cyberknife market. According to the American Society of Clinical Oncology (ASCO), an estimated 268,490 men will be diagnosed with prostate cancer in 2022 in the U.S., and is the most common type of cancer among men. On the other hand, according to the American Cancer Society, lung cancer is the second most common type of cancer and an estimated 236,740 new cases of lung cancer will be diagnosed in 2022.

Increasing preference for non-invasive or minimally invasive procedures is also driving the growth of the cyberknife market. For instance, according to a research study published by the American Society for Radiation Oncology, in October 2020, the number of radiation therapy facilities grew by 17% in the U.S. over the last 15 years.  

                                  CyberKnife Market Segmentation



By Application

  • Tumor
  • Cancer
  • Vascular malformation
  • Others

By End-Use

  • Hospitals
  • Ambulatory surgical centers
  • Specialty Clinics
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa


Based on application, the cancer segment dominated the market due to the increasing usage of cyberknife in the treatment of cancer patients as a primary treatment option as well as in combination with surgeries. Moreover, rapidly rising cancer cases globally are also leading to the dominance of the cancer segment.

On the basis of application, hospitals segment dominated the market. However, the ambulatory surgical centers segment is expected to experience maximum growth as cyberknife technology is used in non-invasive procedures which can be carried out in an outpatient setting as well.

Key players operating in the cyberknife market include Accuray Incorporated, Varian Medical Systems, and Philips Healthcare. Key players in the market are keen on establishing their strong position through the launch of new products. For instance, in June 2020, Accuray launched CyberKnife S7 System, an innovative device that combines advanced precision, speed and real-time artificial intelligence (AI)-driven motion tracking and synchronization treatment delivery for all stereotactic body radiation therapy and stereotactic radiosurgery treatments, in as little as 15 minutes.   

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon